Insightful Interview: McWin’s Martin Davalos on the Future of Food-Tech Investment in 2026

Key Takeaways

  • Investors are prioritizing food-tech companies with clear commercial traction, efficiency, and scalability.
  • Key focus areas include functional ingredients, AI-driven discovery, and foodservice digitalization.
  • Startups must demonstrate a clear path to profitability to attract funding in today’s market.

Investment Landscape in Food-Tech

The food-tech investment landscape in 2026 has undergone a significant correction, with investors now focusing on companies demonstrating clear commercial traction and robust unit economics. Martin Davalos, partner and head of food-tech at McWin, explains that while capital has become more selective, this shift has resulted in a disciplined ecosystem. The focus has moved away from fleeting trends to businesses that have proven their value, effectively eliminating less viable options.

Davalos outlines three critical criteria for backing food-tech startups: a tangible pain point in the food system, measurable commercial evidence like customer demand and gross margins, and defensibility through intellectual property or unique customer relationships. Startups lacking any of these elements are unlikely to receive investment from McWin.

Attention from investors has increasingly shifted upstream, favoring enabling infrastructure over consumer-facing disruptions. Current hotspots include functional ingredients, food-as-medicine platforms, and AI-driven ingredient discovery. There’s also rising interest in foodservice digitalization, which encompasses modernizing ordering and distribution systems, as well as technologies aimed at improving supply chain resilience.

Investment in AgTech presents unique challenges due to longer adoption cycles and stringent ROI requirements from farmers and food manufacturers. Davalos notes that capital intensity increases significantly when hardware is involved, making it harder for AgTech startups to attract funding. However, those with well-defined value propositions can still thrive, particularly in areas focused on precision applications and input efficiency.

The importance of a clear path to profitability has become paramount in the investment evaluation process. While startups do not need to be profitable immediately, they must demonstrate a feasible pathway to achieving profitability, including insights into gross margins and customer acquisition payback periods. Companies that successfully differentiate ambition from unrealistic expectations are more likely to secure funding.

Alternative proteins, which once attracted rapid, speculative investment, have matured into a more realistic sector. Focus has shifted from generic meat replacements to specific applications that tackle formulation and supply-chain challenges. The maturing landscape now favors functional proteins and cultivated meat companies that are centered on process economics.

Emerging technologies warrant attention, specifically the intersection of AI and biology in ingredient discovery and biomanufacturing. Another notable area is the need for GLP-1-linked nutrition products, complementing new therapeutic markets. Additionally, addressing commodity inflation through innovative alternatives for staple ingredients is becoming essential.

Davalos emphasizes that food-tech innovation should not be viewed solely as a consumer story; the most impactful advancements are occurring deeper within the supply chain, including ingredient efficiency and technological solutions, which ultimately contribute to a healthier and more resilient food system.

The content above is a summary. For more details, see the source article.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top